Revenue: The sum of all revenue fields included for a company's operating activities.
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) had Revenue of $14.97M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$14.97M |
$-61.07M |
|
-- |
|
$14.97M |
|
$82.94M |
|
$-67.97M |
|
$6.74M |
|
$-61.23M |
|
$-61.23M |
|
$-61.18M |
|
$-61.18M |
|
$-61.18M |
|
$-61.18M |
|
$-67.97M |
|
$-62.17M |
|
39.35M |
|
39.35M |
|
$-1.55 |
|
$-1.55 |
|
| Balance Sheet Financials | |
$125.74M |
|
$7.37M |
|
$34.59M |
|
$160.33M |
|
$15.66M |
|
-- |
|
$14.54M |
|
$30.19M |
|
$130.13M |
|
$108.19M |
|
$130.13M |
|
40.23M |
|
| Cash Flow Statement Financials | |
$-28.94M |
|
$-0.89M |
|
$2.16M |
|
$142.09M |
|
$112.40M |
|
$-29.69M |
|
$4.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-454.07% |
|
-454.07% |
|
-415.32% |
|
-409.03% |
|
-408.00% |
|
$-29.83M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
2.10 |
|
174.08 |
|
-47.02% |
|
-56.55% |
|
-38.16% |
|
-47.02% |
|
$3.23 |
|
$-0.76 |
|
$-0.74 |
|